Dronedarone: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Dronedarone. Educational only — not medical advice.
Labeled uses
MULTAQ® is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (AF) [see Clinical Studies (14) ] .
Source: FDA labeling via NIH DailyMed (set 3bd4006a…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.